Table 5.
Age | HPV+ | Histology | Total | |||
---|---|---|---|---|---|---|
noCIN | CIN 1–2 | CIN 3 | CxCa | |||
< 30 | Rate [%] | 49.0 | 84.0 | 96.9 | 100 | 72.0 |
95% CI [%] | 34.4–63.7 | 63.0–95.5 | 83.8–99.9 | 5.0–100 | 62.5–80.2 | |
Count | (24/49) | (21/25) | (31/32) | (1/1) | (77/107) | |
≥ 30 | Rate [%] | 30.1 | 80.8 | 94.6 | 100 | 56.3 |
95% CI [%] | 21.8–39.4 | 60.6–93.4 | 85.1–98.9 | 47.3–100 | 49.1–63.3 | |
Count | (34/113) | (21/26) | (53/56) | (4/4) | (112/199) | |
Total | Rate [%] | 35.8 | 82.4 | 95.5 | 100 | 61.8 |
95% CI [%] | 28.4–43.7 | 69.1–91.6 | 88.8–98.7 | 54.9–100 | 56.1–67.2 | |
Count | (58/162) | (42/51) | (84/88) | (5/5) | (189/306) |
hrHPV+ refers to the presence of one or more of the following HPV types: HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68